IA
Inspire Advisors’s Citius Pharmaceuticals CTXR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-157,938
| Closed | -$79.1K | – | 429 |
|
|
2024
Q3 | $79.1K | Sell |
157,938
-306
| -0.2% | -$153 | 0.01% | 416 |
|
|
2024
Q2 | $92.4K | Buy |
158,244
+818
| +0.5% | +$477 | 0.01% | 368 |
|
|
2024
Q1 | $141K | Sell |
157,426
-25,313
| -14% | -$22.7K | 0.02% | 360 |
|
|
2023
Q4 | $138K | Sell |
182,739
-3,671
| -2% | -$2.78K | 0.02% | 325 |
|
|
2023
Q3 | $128K | Sell |
186,410
-12,062
| -6% | -$8.26K | 0.02% | 257 |
|
|
2023
Q2 | $238K | Sell |
198,472
-160
| -0.1% | -$192 | 0.05% | 200 |
|
|
2023
Q1 | $232K | Buy |
198,632
+2,686
| +1% | +$3.14K | 0.05% | 171 |
|
|
2022
Q4 | $155K | Sell |
195,946
-2,459
| -1% | -$1.94K | 0.04% | 164 |
|
|
2022
Q3 | $240K | Buy |
198,405
+1,538
| +0.8% | +$1.86K | 0.07% | 91 |
|
|
2022
Q2 | $181K | Buy |
196,867
+3,152
| +2% | +$2.9K | 0.05% | 94 |
|
|
2022
Q1 | $347K | Buy |
193,715
+4,919
| +3% | +$8.81K | 0.1% | 51 |
|
|
2021
Q4 | $291K | Buy |
188,796
+50,583
| +37% | +$78K | 0.08% | 67 |
|
|
2021
Q3 | $281K | Buy |
138,213
+2,705
| +2% | +$5.5K | 0.09% | 47 |
|
|
2021
Q2 | $472K | Buy |
135,508
+24,721
| +22% | +$86.1K | 0.15% | 32 |
|
|
2021
Q1 | $197K | Buy |
+110,787
| New | +$197K | 0.07% | 65 |
|